An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Clinical trial NCT00526877 · COMPLETED
Trial details
- NCT number
- NCT00526877
- Sponsor
- Johnson & Johnson Taiwan Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-13
- Primary completion
- 2009-01-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.